- Contractors
- Seegene USA, Inc.
Seegene USA, Inc.
Federal contractor · In-Vitro Diagnostic Substance Manufacturing
Seegene USA has 1 federal contract of $100,000 or more active since October 2023, with $122K obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 1 since FY2024$121,950 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Centers for Disease Control and Prevention$122K on 1 contract
- Main industry
- In-Vitro Diagnostic Substance ManufacturingNAICS 325413
- UEI
- YDDKWNE9JAY7Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Eo 14398: Novaplex SystemCenters for Disease Control and Prevention · 75D30126P21232 | $121,950 | Jun 14, 2027in 6 months | CA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Centers for Disease Control and Prevention1 contract | $121,950 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 1 contract | $121,950 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| California1 contract | $121,950 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Centers for Disease Control and Prevention: see the list.
Get new notices like Seegene USA's work
New contract opportunities under NAICS 325413, in-vitro diagnostic substance manufacturing, the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy